Affordable Access

Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma.

Authors
  • Tsai, James C
  • Wu, Li
  • Worgul, Basil
  • Forbes, Max
  • Cao, Jingtai
Type
Published Article
Journal
Current eye research
Publication Date
Nov 01, 2005
Volume
30
Issue
11
Pages
1025–1031
Identifiers
PMID: 16282136
Source
Medline
License
Unknown

Abstract

A single intravitreal 200 ng dose of EPO appears to have a protective effect on RGC viability in an in vivo rat model of glaucoma. Further experimental studies are needed to confirm these preliminary results and to optimize the appropriate dose and frequency of EPO delivery in animal models of glaucoma.

Report this publication

Statistics

Seen <100 times